Management of tracheal and bronchial stenoses with the Gianturco stent.

Carrasco CH, Nesbitt JC, Charnsangavej C, Ryan B, Walsh GL, Yasumori K, Lawrence DD, Wallace S
Ann Thorac Surg. 1994 58 (4): 1012-6; discussion 1017

PMID: 7524459 · DOI:10.1016/0003-4975(94)90446-4

Thirty-six cancer patients with symptomatic tracheobronchial stenoses received Gianturco tracheobronchial stents over a 9-year period. Symptoms improved in 28 patients (78%). The overall median survival was 1 month 3 weeks (range, 4 days to 35 months). The median survival for patients who showed improvement after receiving stents was 3 months compared with 1 week for those who did not respond. Complications were minimal. The Gianturco stent may palliate symptoms of tracheobronchial compression in selected cancer patients.

MeSH Terms (15)

Adult Aged Aged, 80 and over Bronchial Diseases Constriction, Pathologic Female Humans Male Middle Aged Neoplasms Palliative Care Stents Survival Analysis Tracheal Stenosis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: